Medi Assist Healthcare Share Price Surge Over 12% After Promoter Stake Sale

Mumbai, August 12, 2025 – Medi Assist Healthcare Services , a leading health-tech and insurance-tech company, witnessed a remarkable surge in its stock price, climbing over 12% on August 12, 2025, following a significant block deal involving a promoter entity. The stock soared to an intra-day high of ₹594.40, reflecting a 12.68% jump, before settling at ₹567.55 on the BSE, up 7.59% from its previous close. This rally was triggered by a ₹578 crore block deal, which saw approximately 1.1 crore equity shares, equivalent to a 15.67% stake, change hands at ₹523 per share.

Block Deal Sparks Market Frenzy

The block deal, executed on August 12, 2025, has drawn significant attention, though the identity of the promoter entity involved remains undisclosed. According to media reports and some other trusted sources, suggested that Bessemer India Capital Holdings, a key promoter, offloaded a 4% stake in Medi Assist Healthcare for around ₹560 crore. The floor price for this transaction was set at ₹507 per share. Before the deal, Bessemer India held a 15.67% stake in the company as of the June quarter, and post-transaction, its holding is estimated to have dropped to 4.88%.

The significant stake sale has fueled speculation and optimism among investors, contributing to the stock’s sharp upward movement. While some investors capitalized on the rally, the stock’s strong fundamentals and recent performance suggest it remains a compelling investment option.

Stellar Financial Performance

Medi Assist Healthcare’s robust financial results for the April-June 2025 quarter (Q1 FY26) have further bolstered investor confidence. The company reported a 19% year-on-year increase in net profit, reaching ₹22.4 crore, compared to ₹18.8 crore in the same quarter last year. Revenue for the quarter grew by 13.6% to ₹190.5 crore, up from ₹167.7 crore in Q1 FY25. Additionally, operating profit rose by 18.5% to ₹42.2 crore, with the operating margin improving from 21.2% to 22.1%, reflecting enhanced operational efficiency. The company’s strong quarterly performance underscores its leadership in the health-tech and insurance-tech sectors, making it a standout player in India’s rapidly growing digital healthcare market.

Shareholding and Market Dynamics

As of the June 2025 quarter, Medi Assist Healthcare’s shareholding pattern reveals a diverse investor base. Mutual funds hold a 25.6% stake, alternative investment funds own 7%, insurance companies possess 9.5%, and foreign investors account for 17.8%. The promoter stake, which stood at 15.67% before the block deal, has now been significantly reduced, potentially increasing the stock’s free float and liquidity in the market. The company, which was listed on the stock exchanges in January 2024 at ₹418 per share, has seen its stock price fluctuate over the past 19 months. It reached a 52-week high of ₹715 on September 16, 2024, but dipped to a low of ₹400 on February 17, 2025. Despite the recent volatility, analysts remain optimistic, with all three covering analysts recommending a “Buy” rating. Their target prices range between ₹630 and ₹700, signaling confidence in the stock’s growth potential.

Strategic Moves and Future Outlook

Medi Assist Healthcare has been proactive in strengthening its financial position. Earlier this month, the company’s board approved a preferential allotment of 37.01 lakh fully paid-up equity shares to raise ₹198 crore. This capital infusion is expected to support the company’s growth initiatives and further solidify its market position. The block deal and the subsequent share price surge highlight Medi Assist’s strong market appeal, driven by its solid financial performance and strategic initiatives. While the promoter stake sale has reduced their holding, it has also opened opportunities for new investors to participate in the company’s growth story.